<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Clinical chorioamnionitis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Clinical chorioamnionitis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Clinical chorioamnionitis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Alan Thevenet N Tita, MD, PhD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Vincenzo Berghella, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Vanessa A Barss, MD, FACOG</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Sep 07, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Clinical chorioamnionitis is characterized by infection and inflammation of intrauterine structures. It is a common pregnancy complication, especially after prelabor rupture of membranes (PROM). Treatment involves both antibiotic therapy and expeditious delivery. Despite treatment, the disorder is associated with potentially serious maternal, fetal, and neonatal consequences, and offspring may be at increased long-term risk for cerebral palsy and other adverse neurodevelopmental outcomes.</p><p>This topic will discuss clinical manifestations, diagnosis, and treatment of clinical chorioamnionitis. Its occurrence and prevention in patients with preterm prelabor rupture of membranes (PPROM) are reviewed separately. (See  <a class="medical medical_review" href="/d/html/120959.html" rel="external">"Preterm prelabor rupture of membranes: Management and outcome"</a>.) </p><p class="headingAnchor" id="H4096638297"><span class="h1">TERMINOLOGY</span><span class="headingEndMark"> — </span>Historically, the term "clinical chorioamnionitis" referred to infection of the chorion, amnion, or both. Although this term remains in common use, the term intraamniotic infection is also commonly used since infection often involves the amniotic fluid, fetus, and umbilical cord in addition to the membranes. By comparison, the term "histologic chorioamnionitis" has been used by pathologists to describe inflammation without the typical clinical or microbiological findings associated with acute infection; these cases may be the result of sterile inflammation or use of insensitive microbiologic techniques. Adding to the complexity, in 2015, a National Institute of Child Health and Human Development (NICHD) Workshop expert panel recommended use of the term "triple I" to address heterogeneity in terminology [<a href="#rid1">1</a>]. Triple I refers to intrauterine infection or inflammation or both and is defined by strict diagnostic criteria  (<a class="graphic graphic_table graphicRef107670" href="/d/graphic/107670.html" rel="external">table 1</a>). These criteria are commonly used to diagnosis clinical chorioamnionitis even though the triple I terminology has not been adopted by most clinicians [<a href="#rid2">2,3</a>].</p><p>The terms clinical chorioamnionitis and intraamniotic infection will be used interchangeably in this topic. They are often used interchangeably clinically and in the literature since they are indistinguishable antepartum using standard noninvasive tests. However, we recognize that when amniotic fluid culture and interleukin-6 concentration are available, one-quarter to one-third of chorioamnionitis cases will not have evidence of infection that has extended into the amniotic cavity [<a href="#rid4">4</a>]. We also acknowledge that the two conditions may be associated with different risks for adverse outcome.</p><p class="headingAnchor" id="H24363502"><span class="h1">PATHOGENESIS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Migration of cervicovaginal microorganisms through the cervical canal to the decidual-chorionic interface is the most common pathway to chorioamnionitis [<a href="#rid5">5</a>]. The microorganisms can then pass into the amniotic cavity and may eventually infect the fetus. Membrane rupture is not necessary for bacteria to reach the amniotic cavity. </p><p></p><p class="bulletIndent1">Uncommonly, maternal microorganisms in blood seed the intervillous space, resulting in placental infection and transplacental passage of the microorganisms to the fetus. Microorganisms that invade the placenta by the hematogenous route include <em>Listeria monocytogenes</em>, Zika virus, cytomegalovirus, SARS-CoV-2, <em>Plasmodium </em>species, <em>Campylobacter</em> species and microorganisms causing toxoplasmosis, syphilis, varicella-zoster, parvovirus B19, rubella, and herpes infections [<a href="#rid6">6</a>].</p><p></p><p class="bulletIndent1">Another uncommon pathway is microbial contamination of the amniotic cavity from a transmyometrial or transcervical procedure. Rarely, microorganisms from a pelvic infection migrate through the fallopian tubes, resulting in chorioamnionitis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Local host factors also play roles. Most importantly, intact membranes and the cervical mucus plug are barriers to ascending infection that are impaired by membrane rupture and passage of the plug. Other host barriers to infection may also be impaired. For example, the fetal membranes appear to have antimicrobial activity [<a href="#rid7">7-10</a>] and peroxide-producing lactobacilli in the vagina appear to have favorable immunomodulatory effects that impair the virulence of pathogenic organisms [<a href="#rid11">11</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Microbial infection activates the maternal/fetal inflammatory response systems and generally leads to labor and/or prelabor rupture of membranes (PROM). Decidual or amniochorial space inflammation is primarily a maternal inflammatory response while intraamniotic inflammation is primarily a fetal inflammatory response [<a href="#rid5">5</a>]. (See <a class="local">'Histology'</a> below and  <a class="medical medical_review" href="/d/html/6785.html" rel="external">"Spontaneous preterm birth: Pathogenesis", section on '#2 Inflammation'</a>.)</p><p></p><p class="headingAnchor" id="H1082251298"><span class="h1">MICROBIOLOGY</span><span class="headingEndMark"> — </span>Clinical chorioamnionitis from migration of cervicovaginal microorganisms is typically a polymicrobial infection, often involving enteric flora  (<a class="graphic graphic_table graphicRef107698" href="/d/graphic/107698.html" rel="external">table 2</a>). Two-thirds of patients have at least two isolates per specimen of amniotic fluid. By comparison, transplacental infection from microorganisms in the maternal circulation is more likely to be due to a single pathogen, such as <em>L. monocytogenes</em>.</p><p>Regardless of gestational age, genital mycoplasmas (<em>Ureaplasma</em> and <em>Mycoplasma</em> species) are the most common isolates and may be detected in the absence of other organisms [<a href="#rid12">12,13</a>]. Because they are highly prevalent (&gt;70 percent) in the lower genital tract, some authorities attribute their isolation from patients with clinical chorioamnionitis to contamination or colonization from the lower genital tract rather than a true infection. However, as data accrue, their pathogenicity is increasingly supported, including induction of a robust inflammatory response with clinical consequences for both mother and neonate [<a href="#rid12">12-15</a>].</p><p>Other pathogens frequently associated with clinical chorioamnionitis include anaerobes (eg, <em>Gardnerella vaginalis, Bacteroides</em> spp.), enteric Gram-negative bacilli, and group B <em>Streptococcus</em>. Anaerobes appear to be more frequently involved in preterm than in term chorioamnionitis [<a href="#rid16">16</a>].</p><p class="headingAnchor" id="H2"><span class="h1">INCIDENCE</span><span class="headingEndMark"> — </span>Clinical chorioamnionitis occurred in 3.9 percent of births and was the most common peripartum infection in a systematic review evaluating the global incidence of maternal peripartum infection [<a href="#rid17">17</a>]. The incidence in the United States varies widely among individual reports [<a href="#rid18">18</a>]. This variation is due to several factors, including differences in ascertainment (prospective studies report higher rates than retrospective studies), differences in prevalence of risk factors in the populations studied, use of different diagnostic criteria (eg, clinical versus histologic [the incidence of histologic chorioamnionitis is much higher]), and temporal changes in obstetric practice [<a href="#rid19">19-21</a>].</p><p>The incidence is higher in preterm pregnancies. Forty to 70 percent of preterm births have been associated with chorioamnionitis [<a href="#rid22">22</a>]. Among term births, clinical chorioamnionitis has been diagnosed in approximately 1 to 3 percent of those with intact membranes [<a href="#rid23">23</a>] and 6 to 10 percent of those with PROM [<a href="#rid24">24</a>].</p><p class="headingAnchor" id="H5"><span class="h1">RISK FACTORS</span><span class="headingEndMark"> — </span>The most important risk factor for developing clinical chorioamnionitis is longer duration of labor and ruptured membranes. Several other obstetric factors have been associated with an increased risk, including [<a href="#rid20">20,24-35</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Multiple intrapartum digital vaginal examinations (especially after ruptured membranes)</p><p class="bulletIndent1"><span class="glyph">●</span>Prolonged first or second stage of labor</p><p class="bulletIndent1"><span class="glyph">●</span>Prolonged time from rupture of membranes to delivery </p><p class="bulletIndent1"><span class="glyph">●</span>Digital rather than speculum examination in patients with preterm prelabor rupture of membranes (PPROM)</p><p class="bulletIndent1"><span class="glyph">●</span>Cervical insufficiency</p><p class="bulletIndent1"><span class="glyph">●</span>Fetal scalp electrode or internal uterine pressure catheter </p><p class="bulletIndent1"><span class="glyph">●</span>Intracervical balloon catheter for cervical ripening/labor induction</p><p class="bulletIndent1"><span class="glyph">●</span>Presence of genital tract pathogens (eg, sexually transmitted infections, group B <em>Streptococcus</em>, bacterial vaginosis)</p><p class="bulletIndent1"><span class="glyph">●</span>Nulliparity</p><p class="bulletIndent1"><span class="glyph">●</span>Meconium-stained amniotic fluid</p><p class="bulletIndent1"><span class="glyph">●</span>Alcohol and tobacco use</p><p class="bulletIndent1"><span class="glyph">●</span>Previous clinical chorioamnionitis</p><p class="bulletIndent1"><span class="glyph">●</span>Epidural analgesia </p><p></p><p class="headingAnchor" id="H24364408"><span class="h1">CLINICAL FINDINGS</span></p><p class="headingAnchor" id="H24368502"><span class="h2">Presentation</span><span class="headingEndMark"> — </span>Clinical chorioamnionitis often occurs in pregnancies with prelabor rupture of membranes (PROM) but can occur with intact membranes, especially in laboring patients. The key clinical findings, which are nonspecific, and their approximate frequencies are as follows [<a href="#rid36">36,37</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Fever (100 percent).</p><p class="bulletIndent1"><span class="glyph">●</span>Maternal leukocytosis (white blood cell [WBC] count &gt;15,000/mm<sup>3</sup>: 70 to 90 percent).</p><p class="bulletIndent1"><span class="glyph">●</span>Maternal tachycardia (&gt;100 beats per minute [bpm]: 50 to 80 percent).</p><p class="bulletIndent1"><span class="glyph">●</span>Fetal tachycardia (&gt;160 bpm: 40 to 70 percent).</p><p class="bulletIndent1"><span class="glyph">●</span>Uterine tenderness (4 to 25 percent).</p><p class="bulletIndent1"><span class="glyph">●</span>Bacteremia (5 to 10 percent). Bacteremia is most common when clinical chorioamnionitis is associated with group B <em>Streptococcus</em> or <em>Escherichia coli</em> infection (bacteremia in 18 and 15 percent of cases, respectively).</p><p class="bulletIndent1"><span class="glyph">●</span>Purulent or malodorous amniotic fluid.</p><p></p><p>Subclinical cases are not associated with these signs and symptoms, but may lead to labor or PROM and may be associated with reduced fetal heart rate variability [<a href="#rid38">38,39</a>].</p><p class="headingAnchor" id="H24368317"><span class="h2">Maternal course</span><span class="headingEndMark"> — </span>Patients with clinical chorioamnionitis are at increased risk for preterm birth, labor abnormalities, sepsis, postpartum infection, and their sequelae.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Preterm birth </strong>– Chorioamnionitis leads to preterm birth via the following pathways: spontaneous preterm labor with intact membranes, preterm prelabor rupture of membranes (PPROM) leading to spontaneous preterm labor, or medically indicated preterm birth [<a href="#rid40">40</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dysfunctional labor</strong> – Clinical chorioamnionitis is associated with an increased risk of protraction and arrest disorders of labor, which increase the risk for cesarean birth, uterine atony, and postpartum hemorrhage [<a href="#rid41">41-43</a>]. The type of bacteria appears to play a role: Patients with persistent high-virulence organisms (eg, <em>Enterobacteriaceae</em>, Group A and B streptococci, <em>Mycoplasma hominis</em>) in the amniotic fluid have more labor abnormalities than those with low-virulence organisms (<em>Ureaplasma urealyticum, </em>lactobacilli<em>, Staphylococcus epidermidis</em>) [<a href="#rid44">44-48</a>]. The pathophysiologic mechanisms for labor abnormalities related to clinical chorioamnionitis are poorly understood and often complicated by other factors (eg, epidural anesthesia), but the link between clinical chorioamnionitis and both labor abnormalities and postpartum hemorrhage suggests dysfunctional myometrial contractility due to inflammation [<a href="#rid41">41-43,49</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sepsis</strong> – Population-based studies have reported that chorioamnionitis increased the odds of maternal sepsis 8- to 12-fold and approximately 15 to 20 percent of maternal sepsis was associated with chorioamnionitis [<a href="#rid50">50,51</a>]. In a review of a database including 364 patients with clinical chorioamnionitis, five developed severe sepsis (1.4 percent) and it was difficult to identify these patients upon initial presentation despite use of a modified obstetric early warning scoring system  (<a class="graphic graphic_table graphicRef104186" href="/d/graphic/104186.html" rel="external">table 3</a>) [<a href="#rid52">52</a>]. </p><p></p><p class="bulletIndent1">The risk of life-threatening maternal sequelae, such as sepsis, coagulopathy, and adult respiratory distress syndrome related to clinical chorioamnionitis, is low if treatment with broad spectrum antibiotics is initiated upon diagnosis of infection and the pregnancy is delivered. (See <a class="local">'Maternal management'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Postpartum infection </strong>– Patients with clinical chorioamnionitis who undergo cesarean birth, which is common, are at increased risk for wound infection, endomyometritis, septic pelvic thrombophlebitis, and pelvic abscess [<a href="#rid41">41,53,54</a>]. These complications are uncommon after a vaginal birth.</p><p></p><p class="headingAnchor" id="H24368818"><span class="h2">Histology</span><span class="headingEndMark"> — </span>The maternal immune response to microbial infection leads to neutrophilic inflammation of the chorioamnion (chorioamnionitis). A fetal immune response may also occur. The fetal immune response leads to neutrophilic inflammation of the fetal vessels in the chorionic plate (chorionic vasculitis) and, less commonly, the umbilical cord (funisitis). Chorioamnionitis is almost always present in cases of funisitis, while funisitis is present in a minority of chorioamnionitis cases (&lt;60 percent, higher in preterm than term gestations) [<a href="#rid4">4,55</a>]. Chorioamnionitis may be staged 1 to 3 based on the anatomic sites infiltrated by neutrophils and graded 1 to 3 based on the intensity of the acute inflammatory process at a particular site. Histologic criteria for chorioamnionitis and funisitis are reviewed separately. (See  <a class="medical medical_review" href="/d/html/2282.html" rel="external">"The placental pathology report", section on 'Acute chorioamnionitis'</a> and  <a class="medical medical_review" href="/d/html/2282.html" rel="external">"The placental pathology report", section on 'Inflammation'</a>.)</p><p>A histologic diagnosis of chorioamnionitis may be reported in the absence of clinical signs and symptoms of infection or positive cultures from the placenta, membranes, or amniotic fluid. In these cases, the inflammatory changes in the membranes may have resulted from noninfectious insults (hypoxic injury, trauma, meconium, allergens). Negative cultures could also be due to fastidious organisms such as genital mycoplasmas (the most common organisms associated with chorioamnionitis) or antibiotic therapy prior to delivery.</p><p>In one study, histologic and bacteriologic results were concordant in approximately 70 percent of the 376 examined placentas [<a href="#rid56">56</a>]. When the diagnosis of chorioamnionitis was based on culture-positive amniotic fluid, sensitivity and specificity of histology were 83 to 100 percent and 23 to 52 percent, respectively [<a href="#rid57">57</a>].</p><p class="headingAnchor" id="H213624692"><span class="h1">DIAGNOSTIC EVALUATION</span></p><p class="headingAnchor" id="H4218987078"><span class="h2">All patients</span></p><p class="bulletIndent1"><span class="glyph">●</span>Complete blood count.</p><p class="bulletIndent1"><span class="glyph">●</span>Diagnostic studies for infections other than chorioamnionitis, such as pyelonephritis or respiratory infection, are performed if the diagnosis of chorioamnionitis versus another cause of fever and leukocytosis is uncertain. The specific studies are guided by the clinical findings (eg, flank pain, cough, dyspnea). (See <a class="local">'Differential diagnosis'</a> below.)</p><p></p><p>We do not obtain blood cultures in patients with chorioamnionitis unless we suspect maternal sepsis. (See <a class="local">'Evaluation for sepsis'</a> below and  <a class="medical medical_review" href="/d/html/2133.html" rel="external">"Detection of bacteremia: Blood cultures and other diagnostic tests", section on 'Indications for blood cultures'</a>.)</p><p class="headingAnchor" id="H3762556229"><span class="h2">When to perform amniocentesis to test amniotic fluid</span><span class="headingEndMark"> — </span>In the vast majority of patients, a presumptive diagnosis of clinical chorioamnionitis is adequate for initiating maternal therapy, without the need for amniocentesis (see <a class="local">'Diagnosis'</a> below). However, when the presumptive diagnosis is uncertain because typical clinical findings (eg, maternal fever) are absent or findings overlap with other disorders, evaluation of amniotic fluid can confirm or exclude intraamniotic infection. Analysis of amniotic fluid is particularly useful in preterm gestations with an uncertain diagnosis because an incorrect diagnosis of chorioamnionitis leading to unnecessary delivery could result in serious morbidity in offspring.</p><p>Amniotic fluid culture remains the "gold standard" and the most specific test for documentation of intraamniotic infection but utility is limited because it take days to obtain definitive results, which is too long to be clinically useful. Results from several other tests, including Gram stain, glucose concentration, white blood cell (WBC) concentration, and leukocyte esterase level, can be obtained more rapidly; however, the majority of these tests have relatively low predictive value for a positive amniotic fluid culture  (<a class="graphic graphic_table graphicRef142598" href="/d/graphic/142598.html" rel="external">table 4</a>) in patients with preterm prelabor rupture of membranes (PPROM) or preterm labor and even lower ability to predict neonatal sepsis [<a href="#rid58">58,59</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Gram stain</strong> is performed on an unspun specimen of amniotic fluid; centrifugation does not significantly improve test sensitivity. Twenty to 30 high-power fields should be examined. The presence of any bacteria and leukocytes (at least six leukocytes per high-power field) is suspicious for infection since amniotic fluid is sterile in uncomplicated pregnancies with intact membranes [<a href="#rid60">60</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Glucose concentration</strong> is measured with an autoanalyzer. Glucose ≤14 mg/dL suggests infection [<a href="#rid61">61</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>WBC concentration</strong> can be determined using a Coulter counter (abnormal result ≥30 cells/mm<sup>3</sup>) [<a href="#rid62">62</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Leukocyte esterase activity</strong> can be evaluated with a urine dipstick reagent strip (an abnormal result is trace or greater) [<a href="#rid63">63,64</a>].</p><p></p><p>In patients with preterm labor, the combined result of positive Gram stain, positive leukocyte esterase, low glucose concentration, and elevated WBC concentration has 90 percent sensitivity and 80 percent specificity for predicting positive results of amniotic fluid culture. However, since the prevalence of intraamniotic infection is relatively low in patients with preterm labor (approximately 10 percent), this combination of tests has a false-positive rate of 67 percent; thus, the clinician should use caution in acting prior to obtaining culture results, particularly when the intervention involves a performing a preterm birth. In addition, an elevated WBC concentration is less predictive of infection if the amniocentesis is traumatic (defined as amniotic fluid containing ≥1000 red blood cells/mm<sup>3</sup>) [<a href="#rid62">62</a>].</p><p>Some clinicians perform amniocentesis to exclude subclinical intraamniotic infection in selected patients, such as those with preterm labor that is associated with uterine tenderness, elevated maternal white blood cell count, or fetal tachycardia or patients with physical examination-based cervical insufficiency, before attempts are made to prolong pregnancy (ie, tocolysis, cerclage placement) [<a href="#rid65">65</a>]. The author does not routinely perform amniocentesis in such patients because of the poor predictive value of nonculture-based amniotic fluid testing, the 48-hour delay in obtaining definitive culture results, and the lack of data proving that decision-making based on this information reduces maternal/neonatal morbidity.</p><p>Although a small study reported antibiotics eradicated intraamniotic infection (microorganisms identified by culture or polymerase chain reaction) in three of four patients with preterm labor and intact membranes who had a follow-up amniocentesis [<a href="#rid66">66</a>], whether patients with preterm labor or cervical insufficiency should undergo amniocentesis and receive tailored antibiotics and expectant management needs to be investigated in randomized trials looking at short- and long-term outcomes. (See  <a class="medical medical_review" href="/d/html/6774.html" rel="external">"Cervical insufficiency", section on 'Management of patients with subclinical infection on amniocentesis'</a>.)</p><p class="headingAnchor" id="H4087080557"><span class="h2">Evaluation for sepsis</span><span class="headingEndMark"> — </span>Most patients with clinical chorioamnionitis are not septic, which is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. Sepsis should be suspected in patients who meet modified obstetric early warning system criteria  (<a class="graphic graphic_table graphicRef104186" href="/d/graphic/104186.html" rel="external">table 3</a>). Obtaining a lactate level can be helpful in such patients since an elevated level (eg, &gt;2 mmol/L or greater than the laboratory's upper limit of normal) can be a sign of sepsis, correlates with the severity of sepsis, and can be used to follow the therapeutic response. Evaluation for sepsis is reviewed in detail separately. (See  <a class="medical medical_review" href="/d/html/1613.html" rel="external">"Evaluation and management of suspected sepsis and septic shock in adults"</a>.)</p><p class="headingAnchor" id="H1542867566"><span class="h2">Other tests</span><span class="headingEndMark"> — </span>Several biomarkers have been studied but none have been proven to be clinically useful. The most commonly performed tests are for amniotic fluid cytokines and C-reactive protein (CRP). </p><p class="bulletIndent1"><span class="glyph">●</span>A point-of-care test for interleukin-6 in amniotic fluid collected transcervically in patients with ruptured membranes is available in some countries, but does not appear to be a good predictor of maternal-fetal infection [<a href="#rid67">67</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Meta-analyses found no clear evidence to support the use of CRP for the early diagnosis of clinical chorioamnionitis in patients with prelabor rupture of membranes (PROM) [<a href="#rid68">68,69</a>]. Available studies had high heterogeneity, with a wide range for sensitivity and specificity of CRP at various thresholds. </p><p></p><p>Clinical chorioamnionitis is not associated with specific findings on ultrasound imaging [<a href="#rid70">70</a>].</p><p class="headingAnchor" id="H7"><span class="h1">DIAGNOSIS</span></p><p class="headingAnchor" id="H1457755771"><span class="h2">Diagnostic criteria</span><span class="headingEndMark"> — </span>The diagnosis of chorioamnionitis is usually based on clinical findings alone. The key criterion is maternal fever without another identifiable source, which is a manifestation of systemic inflammation; other criteria are insensitive. The following diagnostic criteria are commonly used, with small variations worldwide. They were suggested by a National Institute of Child Health and Human Development (NICHD) Workshop expert panel [<a href="#rid1">1</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Presumptive diagnosis</strong> – A presumptive diagnosis of intraamniotic infection can be made in pregnant patients with:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Fever</strong> – Either an oral temperature ≥39.0°C (102.2°F) once <strong>or</strong> 38.0°C (100.4°F) to 38.9°C (102.02°F) on ≥2 measurements 30 minutes apart without another clear source <strong>PLUS</strong> one or more of the following:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Baseline fetal heart rate &gt;160 bpm for ≥10 minutes, excluding accelerations, decelerations, and periods of marked variability.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Maternal white cell (WBC) count &gt;15,000/mm<sup>3</sup> in the absence of corticosteroids and ideally showing a left shift (bandemia).</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Purulent-appearing fluid coming from the cervical os visualized by speculum examination.</p><p></p><p class="bulletIndent1">The rationale for these criteria is that the temperature and fetal heart rate thresholds exceed the 90 to 95<sup>th</sup> percentile for normal pregnancies and the WBC count exceeds the 80<sup>th</sup> percentile. In addition, these thresholds are associated with higher rates of neonatal and maternal morbidity and, in preterm gestations, define a population whose amniotic fluid contains higher concentrations of organisms (&gt;100 colony forming units/mL bacteria) and high-virulence isolates (group B <em>Streptococcus</em>, aerobic Gram-negative rods, anaerobes, and <em>M. hominis</em>). The NICHD criteria do not include maternal tachycardia (heart rate &gt;100 bpm) and fundal tenderness for clinical diagnosis; however, these signs (which are part of the Gibbs criteria [<a href="#rid44">44</a>]) are used by many clinicians in combination with other criteria for presumptive diagnosis.</p><p></p><p class="bulletIndent1">The American College of Obstetricians and Gynecologists (ACOG) generally endorses the NICHD criteria, except ACOG would make a presumptive diagnosis in patients with isolated fever ≥39.0°C (102.2°F) without another clear source because they are at high risk of an adverse clinical infectious outcome and thus should be managed similar to patients with additional signs of intraamniotic infection [<a href="#rid3">3,71</a>]. The presumptive diagnosis in laboring patients with isolated fever is strengthened in those with risk factors for the disease, especially ruptured membranes, and by excluding other potential sources of fever. (See  <a class="medical medical_review" href="/d/html/4453.html" rel="external">"Intrapartum fever"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Confirmed diagnosis</strong> – A confirmed diagnosis of intraamniotic infection can be made in pregnant/postpartum patients with:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>All of the above criteria for suspected intraamniotic infection PLUS </strong>one or more of the following objective laboratory findings:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Positive Gram stain of amniotic fluid.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Low glucose level (≤14 mg/dL) in amniotic fluid.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Positive amniotic fluid culture.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>High WBC count (&gt;30 cells/mm<sup>3</sup>) in amniotic fluid in the absence of a bloody tap.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Histopathologic evidence of infection or inflammation or both in the placenta, fetal membranes, or the umbilical cord vessels (funisitis).</p><p></p><p class="bulletIndent1">Laboratory studies should be performed on amniotic fluid obtained by amniocentesis (not collected vaginally) (see <a class="local">'When to perform amniocentesis to test amniotic fluid'</a> above). Histopathology is obtained after delivery.</p><p></p><p class="headingAnchor" id="H3429215691"><span class="h2">Differential diagnosis</span><span class="headingEndMark"> — </span>Most of the clinical findings associated with chorioamnionitis are nonspecific. Differential diagnosis includes, but is not limited to:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Labor</strong> – Labor can be associated with fever, maternal and/or fetal tachycardia, leukocytosis, and uterine tenderness. Fever may be related to dehydration, use of prostaglandins for cervical ripening, or neuraxial anesthesia. Maternal leukocytosis occurs with labor and after antenatal corticosteroid therapy, as well as with infections other than chorioamnionitis. Fetal tachycardia may be related to fetal hypoxemia, maternal fever of any etiology, or transplacental passage of some maternal medications. Maternal tachycardia may be physiologic or related to pain, medications, or neuraxial anesthesia.</p><p></p><p class="bulletIndent1">Diagnosis of clinical chorioamnionitis is difficult in laboring patients with neuraxial anesthesia because fever is common in this setting and may be related to the anesthetic itself. In addition, neuraxial anesthesia masks uterine tenderness and may induce maternal or fetal tachycardia. Lastly, prolonged labor is a risk factor for both requesting neuraxial anesthesia and developing chorioamnionitis. No specific temperature threshold has been found to reliably distinguish chorioamnionitis from neuraxial anesthesia-associated temperature elevation. (See  <a class="medical medical_review" href="/d/html/4453.html" rel="external">"Intrapartum fever", section on 'Use of neuraxial anesthesia'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Placental abruption</strong> – A small abruption can cause uterine tenderness and maternal tachycardia, but is usually associated with vaginal bleeding and absence of fever. (See  <a class="medical medical_review" href="/d/html/6826.html" rel="external">"Acute placental abruption: Pathophysiology, clinical features, diagnosis, and consequences"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other infections</strong> – Extrauterine infections associated with fever (with or without labor) include pyelonephritis, influenza, appendicitis, pneumonia, and COVID-19. These infections can cause maternal tachycardia, leukocytosis, and sometimes abdominal pain; and fetal tachycardia. They can usually be differentiated from chorioamnionitis by the clinical setting (eg, respiratory or gastrointestinal symptoms suggest an extrauterine source of fever) and laboratory tests (pyuria in urine obtained via a catheter suggests pyelonephritis). (See  <a class="medical medical_review" href="/d/html/4453.html" rel="external">"Intrapartum fever"</a>.)</p><p></p><p class="headingAnchor" id="H14"><span class="h1">MATERNAL MANAGEMENT</span></p><p class="headingAnchor" id="H3471316224"><span class="h2">Initiate delivery</span><span class="headingEndMark"> — </span>Patients with chorioamnionitis should be treated with antibiotics and delivered. Although antimicrobial therapy provides bactericidal concentrations of antibiotics in the fetus and amniotic fluid within one-half to one hour after infusion, which reduces the risk of serious maternal and fetal complications, delivery (ie, evacuation of the products of conception) is required for resolution of the infection. The reason antibiotics alone are ineffective may be because amniotic fluid bacteria can form biofilms, which are resistant to antibiotic treatment [<a href="#rid18">18</a>].</p><p>Patients who are not in labor are promptly induced, unless a standard indication for cesarean birth exists. In patients receiving antibiotics, there is no evidence that the duration of labor correlates with adverse neonatal outcome; therefore, cesarean birth is not indicated to shorten labor duration [<a href="#rid41">41,72</a>]. Furthermore, cesarean birth in the setting of intraamniotic infection increases the risks for wound infection, endomyometritis, and venous thrombosis [<a href="#rid54">54</a>].</p><p>Histopathologic evaluation of the placenta is recommended. We do not typically obtain placental cultures, but cultures may be obtained by the pathologist in selected cases when specific infections, such as listeriosis or candida, are suspected. (See  <a class="medical medical_review" href="/d/html/5393.html" rel="external">"Gross examination of the placenta", section on 'Obtaining cultures'</a>.)</p><p class="headingAnchor" id="H15"><span class="h2">Antibiotic therapy</span><span class="headingEndMark"> — </span>Broad spectrum parenteral antibiotics for common cervicovaginal pathogens should be administered promptly following a diagnosis of chorioamnionitis, even if neuraxial-related fever cannot be excluded. Early initiation of antibiotics begins treatment of maternal and fetal infection and may reduce the frequency and severity of neonatal infection [<a href="#rid73">73-75</a>]. </p><p class="headingAnchor" id="H2987343931"><span class="h3">Intrapartum regimen</span></p><p class="headingAnchor" id="H3956798961"><span class="h4">Laboring patients</span><span class="headingEndMark"> — </span>Our preference for patients expected to give birth vaginally is:</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="8737" href="/d/drug information/8737.html" rel="external">Ampicillin</a> 2 g IV every six hours <strong>plus</strong></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="8489" href="/d/drug information/8489.html" rel="external">Gentamicin</a> 5 mg/kg IV once daily</p><p></p><p class="bulletIndent1">A single daily <a class="drug drug_general" data-topicid="8489" href="/d/drug information/8489.html" rel="external">gentamicin</a> dose is as, or more, effective and more convenient than thrice-daily dosing and safe when used intrapartum or postpartum [<a href="#rid76">76,77</a>]. It does not result in toxic maternal levels (peak 18.2 micrograms/mL and &lt;2 micrograms/mL by 10 hours) and results in appropriate fetal serum levels (peak 6.9 micrograms/mL); fetal levels are lower with standard dosing (1.5 mg/kg every eight hours: fetal level 2.9 micrograms/mL) [<a href="#rid78">78</a>]. Routine monitoring gentamicin levels is unnecessary for patients who are healthy except for chorioamnionitis. For patients with chronic kidney disease, we adjust the gentamicin dose with the assistance of a clinical pharmacist or other expert; serum levels and creatinine clearance are monitored to guide dosing. (See  <a class="medical medical_review" href="/d/html/475.html" rel="external">"Dosing and administration of parenteral aminoglycosides"</a>.)</p><p></p><p>Comparative trials of antibiotic regimens have been few and small, often with design limitations, thus precluding strong recommendations regarding the preferred antibiotic regimen [<a href="#rid79">79</a>]. Some reasonable alternative IV antibiotic regimens are shown in the table  (<a class="graphic graphic_table graphicRef141583" href="/d/graphic/141583.html" rel="external">table 5</a>).</p><p class="headingAnchor" id="H1843585806"><span class="h4">Cesarean birth</span><span class="headingEndMark"> — </span>In patients with chorioamnionitis who will undergo a cesarean birth, we suggest adding anaerobic coverage to the intrapartum regimen because anaerobes play a major role in postsurgical infections. The addition of anaerobic coverage may reduce the risk of developing such infections [<a href="#rid79">79-81</a>] and has been proven to reduce treatment failure in patients with endometritis [<a href="#rid77">77</a>]. </p><p>Our preference is:</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="8737" href="/d/drug information/8737.html" rel="external">Ampicillin</a> 2 g IV every six hours <strong>plus</strong></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="8489" href="/d/drug information/8489.html" rel="external">Gentamicin</a> 5 mg/kg IV once daily <strong>plus</strong></p><p class="bulletIndent1"><span class="glyph">●</span>Either <a class="drug drug_general" data-topicid="9646" href="/d/drug information/9646.html" rel="external">metronidazole</a> 500 mg IV <strong>or </strong><a class="drug drug_general" data-topicid="9275" href="/d/drug information/9275.html" rel="external">clindamycin</a> 900 mg IV every eight hours</p><p></p><p>The author also administers a single dose of <a class="drug drug_general" data-topicid="9041" href="/d/drug information/9041.html" rel="external">azithromycin</a> 500 mg IV, as this is part of his routine antibiotic prophylaxis for cesarean birth to provide broad spectrum coverage that includes ureaplasmas [<a href="#rid82">82,83</a>]. Although azithromycin is commonly used for antibiotic prophylaxis in patients undergoing cesarean birth during labor or after membrane rupture  (<a class="graphic graphic_table graphicRef87200" href="/d/graphic/87200.html" rel="external">table 6</a>), evidence of effectiveness in the setting of patients with chorioamnionitis who are receiving other antibiotics remains to be established and requires study. </p><p class="headingAnchor" id="H2339420409"><span class="h4">Penicillin allergy</span><span class="headingEndMark"> — </span>Evidence-based data to guide the treatment of chorioamnionitis in patients with a penicillin allergy are lacking. </p><p class="bulletIndent1"><span class="glyph">●</span>At the author's institution, <a class="drug drug_general" data-topicid="8737" href="/d/drug information/8737.html" rel="external">ampicillin</a> is replaced with <a class="drug drug_general" data-topicid="10037" href="/d/drug information/10037.html" rel="external">vancomycin</a>: </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_general" data-topicid="8489" href="/d/drug information/8489.html" rel="external">Gentamicin</a> 5 mg/kg once daily <strong>plus</strong> <a class="drug drug_general" data-topicid="10037" href="/d/drug information/10037.html" rel="external">vancomycin</a>, typically 15 to 20 mg/kg IV every 8 to 12 hours for most patients with normal kidney function based on actual body weight, rounded to the nearest 250 mg increment. Dosing and monitoring for patients who require therapy for more than two to three days are described separately. (See  <a class="medical medical_review" href="/d/html/484.html" rel="external">"Vancomycin: Parenteral dosing, monitoring, and adverse effects in adults", section on 'Subsequent maintenance dose/interval'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>An acceptable alternative is:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_general" data-topicid="8489" href="/d/drug information/8489.html" rel="external">Gentamicin</a> 5 mg/kg once daily <strong>plus</strong> <a class="drug drug_general" data-topicid="9275" href="/d/drug information/9275.html" rel="external">clindamycin</a> 900 mg IV every eight hours, except when group B <em>Streptococcus </em>coverage is needed. In these cases, clindamycin should only be used if clindamycin-inducible resistance testing is negative. (See  <a class="medical medical_review" href="/d/html/438.html" rel="external">"Prevention of early-onset group B streptococcal disease in neonates", section on 'Patients with penicillin allergy'</a>.)</p><p></p><p class="headingAnchor" id="H17"><span class="h2">Fetal monitoring during labor</span><span class="headingEndMark"> — </span>Continuous electronic fetal monitoring is the usual approach. Fetal compromise may develop due to sequelae of chorioamnionitis (villous edema, hyperthermic stress, fetal infection) or other factors. Fetal infection is not associated with a specific pattern of periodic fetal heart rate changes, except mild baseline tachycardia in some cases, which is a category II tracing. Management of category II tracings is reviewed separately. (See  <a class="medical medical_review" href="/d/html/16663.html" rel="external">"Intrapartum category I, II, and III fetal heart rate tracings: Management"</a>.)</p><p>While there is no evidence suggesting that use of a scalp electrode increases the risk of neonatal sepsis in the setting of chorioamnionitis, it is prudent to limit its use to pregnancies in which an external device does not provide adequate information.</p><p class="headingAnchor" id="H24368953"><span class="h2">Antipyretics</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="9242" href="/d/drug information/9242.html" rel="external">Acetaminophen</a> is typically administered to reduce fever. The combination of maternal fever and fetal acidosis conferred a 12.5 percent risk of neonatal encephalopathy (odds ratio [OR] 94, 95% CI 29-307) in one study, and each of these factors also appeared to have an independent effect (fever OR 8.1, 95% CI 3.5-18.6; neonatal acidosis OR 11.5, 95% CI 5.0-26.5) [<a href="#rid84">84</a>]. </p><p>Antipyretic therapy may also avoid fever-related fetal tachycardia, which is useful since an abnormal fetal heart rate is a factor in decision-making regarding need for cesarean birth. </p><p class="headingAnchor" id="H1873346867"><span class="h2">Postpartum care</span><span class="headingEndMark"> — </span>Postpartum care is routine, except for additional doses of antibiotic therapy.</p><p class="headingAnchor" id="H2045163280"><span class="h3">Duration of antibiotic therapy</span><span class="headingEndMark"> — </span>The optimal duration of postpartum parenteral antibiotic therapy has not been determined conclusively. There is <strong>no</strong> evidence that oral antibiotics are beneficial after discontinuation of parenteral therapy [<a href="#rid85">85</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>After a vaginal birth – Practice varies regarding use of postpartum antibiotics after vaginal birth. The author of this topic administers one additional dose of antibiotics (<a class="drug drug_general" data-topicid="8737" href="/d/drug information/8737.html" rel="external">ampicillin</a> plus <a class="drug drug_general" data-topicid="8489" href="/d/drug information/8489.html" rel="external">gentamicin</a>) after vaginal birth, whereas other experts (including the section editor of this topic) do not. The American College of Obstetricians and Gynecologists (ACOG) committee opinion on intraamniotic infection states that additional antibiotic doses are not required after vaginal birth [<a href="#rid3">3</a>]. The available clinical trials have not demonstrated a clear benefit of postpartum antibiotic therapy for patients with chorioamnionitis [<a href="#rid79">79</a>]. However, the trials had important limitations (small size, incomplete follow-up) and may have been underpowered to detect a meaningful difference. Thus, the author of the topic continues to provide a dose of postpartum antibiotic therapy to ensure adequate treatment of the infection.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>After a cesarean birth, the author of this topic administers additional postpartum doses of the intrapartum antibiotic regimen until the patient is afebrile and asymptomatic for at least 48 hours. However, administering only one additional dose of this regimen or continuing the regimen until the patient is afebrile and asymptomatic for at least 24 hours are reasonable alternatives (particularly for patients without obesity), given the low quality of available evidence. The author's approach is based on limited data that persistent fever in patients with chorioamnionitis is more common after cesarean birth (15 versus 1 percent after vaginal birth) and serious complications in patients with chorioamnionitis primarily occur after cesarean birth [<a href="#rid86">86</a>].</p><p></p><p class="headingAnchor" id="H1738437721"><span class="h3">Maternal course</span><span class="headingEndMark"> — </span>Chorioamnionitis usually resolves rapidly after delivery, particularly after vaginal birth. Patients with persistent fever and/or pelvic pain should be evaluated for endometritis, wound infection, and, rarely, septic pelvic thrombophlebitis. (See  <a class="medical medical_review" href="/d/html/5488.html" rel="external">"Postpartum endometritis"</a> and  <a class="medical medical_review" href="/d/html/4459.html" rel="external">"Cesarean birth: Postoperative care, complications, and long-term sequelae", section on 'Wound complications'</a> and  <a class="medical medical_review" href="/d/html/2130.html" rel="external">"Septic pelvic thrombophlebitis"</a>.)</p><p class="headingAnchor" id="H18"><span class="h1">PERINATAL OUTCOME</span><span class="headingEndMark"> — </span>Variations among studies in the criteria used for diagnosis of chorioamnionitis and assessment of perinatal outcome make it difficult to compare data across studies and draw conclusions.</p><p class="headingAnchor" id="H2795246259"><span class="h2">Adverse effects</span><span class="headingEndMark"> — </span>Chorioamnionitis is associated with a 2- to 3.5-fold increase in risk of adverse perinatal outcome [<a href="#rid87">87</a>]. Adverse outcomes include perinatal death, asphyxia, early-onset neonatal sepsis, septic shock, respiratory distress syndrome, pneumonia, meningitis, intraventricular hemorrhage (IVH), cerebral white matter damage, necrotizing enterocolitis, and bronchopulmonary dysplasia [<a href="#rid87">87-90</a>]. Among pregnancies with clinical chorioamnionitis, 6 percent of neonates have been diagnosed with early-onset neonatal sepsis [<a href="#rid90">90</a>]. Among newborns with early-onset neonatal sepsis, up to 40 percent have been associated with clinical chorioamnionitis [<a href="#rid37">37</a>].</p><p>A substantial proportion of adverse perinatal outcome is mediated by preterm birth. In one study, the comparative rates of complications for preterm versus term cases of chorioamnionitis were: perinatal death (25 versus 6 percent), neonatal sepsis (28 versus 6 percent), respiratory distress (62 versus 35 percent), pneumonia (20 versus 3 percent), and grade 3 or 4 IVH (24 versus 8 percent) [<a href="#rid91">91</a>].</p><p class="headingAnchor" id="H19"><span class="h2">Neurodevelopmental impairment</span><span class="headingEndMark"> — </span>Many studies, but not all, report that chorioamnionitis is associated with potential long-term disabilities, such as neurodevelopmental delay and cerebral palsy [<a href="#rid92">92,93</a>]. Although the relationship is largely mediated by preterm birth, these adverse outcomes are also observed at or near term [<a href="#rid92">92</a>]. </p><p>In a meta-analysis of the relationship between chorioamnionitis and cerebral palsy, significant associations were observed between cerebral palsy and both clinical chorioamnionitis (pooled odds ratio [OR] 2.42, 95% CI 1.52-3.84) and histologic chorioamnionitis (pooled OR 1.83, 95% CI 1.17-2.89) [<a href="#rid92">92</a>]. However, the analysis was limited by many potential biases, such as differences in definitions and diagnostic criteria across studies, extent of blinding in determining exposure status, and whether the study controlled for potential confounders. A subsequent secondary analysis of data from 1574 newborns of patients at high risk for preterm birth &lt;32 weeks enrolled in one clinical trial reported an association between neurocognitive deficits at two years of age and proven neonatal sepsis but not with clinical chorioamnionitis [<a href="#rid94">94</a>]. The mean gestational age of these infants at birth was 29+3<sup> </sup>weeks.</p><p>Neurodevelopmental impairment associated with chorioamnionitis may involve multiple factors, including asphyxia and toxic injury by bacterial products. Fetal infection/inflammation is likely a more important predictor of neonatal outcome than isolated maternal, amniotic fluid, or amniochorion infection/inflammation [<a href="#rid95">95</a>]. The term systemic fetal inflammatory syndrome (also known as fetal inflammatory response syndrome) refers to the fetal immune response to intrauterine infection and the potential consequences of this response: preterm labor, fetal growth restriction, severe neonatal morbidity, brain injury, and development of chronic lung disease in the child [<a href="#rid96">96-106</a>]. Funisitis and chorionic vasculitis appear to be the placental histologic manifestations of fetal inflammatory response syndrome and markers for adverse outcome [<a href="#rid105">105,107-109</a>]. Laboratory findings include fetal plasma interleukin-6 concentration &gt;11 pg/mL [<a href="#rid96">96,110</a>].</p><p>Neuroinflammation during the perinatal period can increase the risk of long-term neurologic and neuropsychiatric disease [<a href="#rid111">111</a>]. High fetal/neonatal levels of cytokines and chemokines, especially tumor necrosis factor [<a href="#rid103">103</a>], appear to mediate fetal/neonatal brain injury [<a href="#rid98">98,101,103,112-114</a>]. These inflammatory substances can cause cerebral ischemia and damage, ultimately leading to IVH and periventricular leukomalacia. Intervention, such as maternal treatment with an anti-inflammatory cytokine, to prevent these outcomes is one area of investigation [<a href="#rid104">104,115</a>].</p><p class="headingAnchor" id="H953598879"><span class="h2">Newborn evaluation and care</span><span class="headingEndMark"> — </span>(See  <a class="medical medical_review" href="/d/html/5043.html" rel="external">"Clinical features, evaluation, and diagnosis of sepsis in term and late preterm neonates", section on 'Evaluation and initial management'</a>.)</p><p class="headingAnchor" id="H24372776"><span class="h1">PREVENTION</span><span class="headingEndMark"> — </span>One strategy to prevent chorioamnionitis is administration of prophylactic antibiotics to patients with preterm prelabor rupture of membranes (PPROM), which reduces the incidence of clinical chorioamnionitis, prolongs latency, and improves neonatal outcomes. The evidence for this approach is reviewed separately (see  <a class="medical medical_review" href="/d/html/120959.html" rel="external">"Preterm prelabor rupture of membranes: Management and outcome", section on 'Administer prophylactic antibiotic therapy'</a>). For patients with term prelabor rupture of membranes (PROM), we prefer delivery, rather than expectant management plus antibiotic prophylaxis. (See  <a class="medical medical_review" href="/d/html/6757.html" rel="external">"Prelabor rupture of membranes at term: Management", section on 'Antibiotic prophylaxis'</a>.)</p><p>Attention to modifiable risk factors may also reduce the incidence of chorioamnionitis. Modifiable risk factors that pertain to the health care provider include use of a speculum rather than digital examinations in patients with PPROM, conduct of labor (eg, minimizing the number of vaginal examinations), and use of prophylactic antibiotics in patients with group B <em>Streptococcus</em> colonization (see <a class="local">'Risk factors'</a> above and  <a class="medical medical_review" href="/d/html/438.html" rel="external">"Prevention of early-onset group B streptococcal disease in neonates"</a>). Modifiable risk factors that the patient can control include avoidance of tobacco and alcohol. (See <a class="local">'Risk factors'</a> above.)</p><p class="headingAnchor" id="H781998789"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/112235.html" rel="external">"Society guideline links: Group B streptococcal infection in pregnant women and neonates"</a> and  <a class="medical medical_society_guidelines" href="/d/html/113525.html" rel="external">"Society guideline links: Labor"</a>.)</p><p class="headingAnchor" id="H21"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Terminology</strong> – Clinical chorioamnionitis and intraamniotic infection are commonly used terms to describe infection of the fetal membranes. The infection also may involve the amniotic fluid, fetus, umbilical cord, decidua, and placenta. (See <a class="local">'Terminology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Microbiology and pathogenesis</strong> – Clinical chorioamnionitis is typically polymicrobial  (<a class="graphic graphic_table graphicRef107698" href="/d/graphic/107698.html" rel="external">table 2</a>) and usually results from ascending migration of cervicovaginal flora. Other sources include transplacental infection from microorganisms in maternal blood in the intervillous space and microbial contamination from transmyometrial or transcervical procedures. (See <a class="local">'Microbiology'</a> above and <a class="local">'Pathogenesis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations </strong>– Clinical chorioamnionitis usually occurs in pregnancies with prelabor rupture of membranes (PROM) or preterm labor with intact membranes. The key clinical findings and their approximate frequencies are:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Fever (100 percent)</p><p class="bulletIndent2"><span class="glyph">•</span>Maternal leukocytosis (white blood cell [WBC] count &gt;15,000/mm<sup>3</sup>: 70 to 90 percent)</p><p class="bulletIndent2"><span class="glyph">•</span>Maternal tachycardia (&gt;100 beats per minute [bpm]: 50 to 80 percent)</p><p class="bulletIndent2"><span class="glyph">•</span>Fetal tachycardia (&gt;160 bpm: 40 to 70 percent)</p><p class="bulletIndent2"><span class="glyph">•</span>Uterine tenderness (4 to 25 percent)</p><p class="bulletIndent2"><span class="glyph">•</span>Bacteremia (5 to 10 percent) </p><p class="bulletIndent2"><span class="glyph">•</span>Purulent or malodorous amniotic fluid</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> – Criteria for presumptive and confirmed diagnosis of chorioamnionitis are shown in the table  (<a class="graphic graphic_table graphicRef107670" href="/d/graphic/107670.html" rel="external">table 1</a>). (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Role of amniocentesis </strong>– In the vast majority of patients, a presumptive diagnosis of clinical chorioamnionitis is adequate for initiating maternal therapy, without the need for amniocentesis. However, when the presumptive diagnosis is uncertain because typical clinical findings (eg, maternal fever) are absent or findings overlap with other disorders, evaluation of amniotic fluid can confirm or exclude intraamniotic infection. Amniotic fluid culture is the "gold standard" and the most specific test for documentation of intraamniotic infection but utility is limited because it take days to obtain definitive results. Results from Gram stain, glucose concentration, WBC concentration, and leukocyte esterase level can be used but have relatively low sensitivity and specificity for a positive amniotic fluid culture  (<a class="graphic graphic_table graphicRef142598" href="/d/graphic/142598.html" rel="external">table 4</a>). (See <a class="local">'When to perform amniocentesis to test amniotic fluid'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatment</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Initiate delivery</strong> – Clinical chorioamnionitis cannot be cured medically without delivery; therefore, patients who are not in labor are promptly induced, unless a standard indication for cesarean birth exists. In patients receiving antibiotics, there is no evidence that the duration of labor correlates with adverse neonatal outcome; therefore, cesarean birth is not indicated to shorten labor duration. (See <a class="local">'Initiate delivery'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Intrapartum antibiotic regimen</strong> – Broad spectrum antibiotics should be started as soon as a presumptive diagnosis is made and continued through delivery to minimize maternal and fetal morbidity  (<a class="graphic graphic_table graphicRef141583" href="/d/graphic/141583.html" rel="external">table 5</a>). We suggest <a class="drug drug_general" data-topicid="8737" href="/d/drug information/8737.html" rel="external">ampicillin</a> plus <a class="drug drug_general" data-topicid="8489" href="/d/drug information/8489.html" rel="external">gentamicin</a> rather than other regimens (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). For patients undergoing cesarean birth, we suggest adding <a class="drug drug_general" data-topicid="9275" href="/d/drug information/9275.html" rel="external">clindamycin</a> or <a class="drug drug_general" data-topicid="9646" href="/d/drug information/9646.html" rel="external">metronidazole</a> to this regimen preoperatively (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>), given the increased risk of postsurgical anaerobic infection in this setting. Some experts (including the author of this topic) also provide a single dose of <a class="drug drug_general" data-topicid="9041" href="/d/drug information/9041.html" rel="external">azithromycin</a> before a cesarean birth, whereas other experts (including the section editor) do not. (See <a class="local">'Intrapartum regimen'</a> above.)</p><p></p><p class="bulletIndent2">Substitutions are needed for penicillin-allergic patients. (See <a class="local">'Penicillin allergy'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Duration of antibiotic therapy</strong> </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>After vaginal birth, practice varies regarding use of postpartum antibiotics. Acceptable options are to either discontinue antibiotics or provide one additional dose of antibiotics (<a class="drug drug_general" data-topicid="8737" href="/d/drug information/8737.html" rel="external">ampicillin</a> plus <a class="drug drug_general" data-topicid="8489" href="/d/drug information/8489.html" rel="external">gentamicin</a>). (See <a class="local">'Postpartum care'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>After cesarean birth, postpartum antibiotics (<a class="drug drug_general" data-topicid="8737" href="/d/drug information/8737.html" rel="external">ampicillin</a> plus <a class="drug drug_general" data-topicid="8489" href="/d/drug information/8489.html" rel="external">gentamicin</a> plus <a class="drug drug_general" data-topicid="9275" href="/d/drug information/9275.html" rel="external">clindamycin</a> or <a class="drug drug_general" data-topicid="9646" href="/d/drug information/9646.html" rel="external">metronidazole</a> but not <a class="drug drug_general" data-topicid="9041" href="/d/drug information/9041.html" rel="external">azithromycin</a>) are usually continued for 24 to 48 hours. Some experts (including the author of this topic) continue antibiotic therapy until the patient is afebrile and asymptomatic for at least 48 hours; other experts (including the section editor) discontinue antibiotics after 24 hours if the patient is afebrile. (See <a class="local">'Postpartum care'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sequelae</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Maternal</strong> – In addition to maternal infectious complications (eg, postpartum endometritis, sepsis), clinical chorioamnionitis may impair myometrial contractility, which can result in labor abnormalities, need for cesarean birth, uterine atony, and postpartum hemorrhage. Cesarean birth in the presence of clinical chorioamnionitis increases the risk of wound infection, endomyometritis, septic pelvic thrombophlebitis, and pelvic abscess. (See <a class="local">'Maternal course'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Neonatal</strong> – Adverse neonatal outcomes associated with clinical chorioamnionitis include perinatal death, asphyxia, early-onset neonatal sepsis, septic shock, respiratory distress syndrome, pneumonia, meningitis, intraventricular hemorrhage (IVH), necrotizing enterocolitis, and bronchopulmonary dysplasia. Potential long-term disabilities include neurodevelopmental delay and cerebral palsy. Preterm birth mediates a substantial proportion of these outcomes. (See <a class="local">'Perinatal outcome'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prevention </strong>– The main strategy to prevent clinical chorioamnionitis is administration of prophylactic antibiotics to patients with preterm prelabor rupture of membranes (PPROM). Other strategies include use of a speculum rather than digital examinations in patients with PPROM, minimizing the number of intrapartum vaginal examinations (particularly after membrane rupture), and use of prophylactic intrapartum antibiotics in patients with group B <em>Streptococcus</em> colonization. (See <a class="local">'Prevention'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Higgins RD, Saade G, Polin RA, et al. Evaluation and Management of Women and Newborns With a Maternal Diagnosis of Chorioamnionitis: Summary of a Workshop. Obstet Gynecol 2016; 127:426.</a></li><li><a class="nounderline abstract_t">Barth WH Jr. Lost in Translation: The Changing Language of Our Specialty. Obstet Gynecol 2016; 127:423.</a></li><li><a class="nounderline abstract_t">Committee Opinion No. 712: Intrapartum Management of Intraamniotic Infection. Obstet Gynecol 2017; 130:e95. Reaffirmed 2022.</a></li><li><a class="nounderline abstract_t">Romero R, Pacora P, Kusanovic JP, et al. Clinical chorioamnionitis at term X: microbiology, clinical signs, placental pathology, and neonatal bacteremia - implications for clinical care. J Perinat Med 2021; 49:275.</a></li><li><a class="nounderline abstract_t">Park CW, Moon KC, Park JS, et al. The involvement of human amnion in histologic chorioamnionitis is an indicator that a fetal and an intra-amniotic inflammatory response is more likely and severe: clinical implications. Placenta 2009; 30:56.</a></li><li><a class="nounderline abstract_t">Cappelletti M, Presicce P, Kallapur SG. Immunobiology of Acute Chorioamnionitis. Front Immunol 2020; 11:649.</a></li><li><a class="nounderline abstract_t">Kjaergaard N, Hein M, Hyttel L, et al. Antibacterial properties of human amnion and chorion in vitro. Eur J Obstet Gynecol Reprod Biol 2001; 94:224.</a></li><li><a class="nounderline abstract_t">Stock SJ, Kelly RW, Riley SC, Calder AA. Natural antimicrobial production by the amnion. Am J Obstet Gynecol 2007; 196:255.e1.</a></li><li><a class="nounderline abstract_t">Kim YM, Romero R, Chaiworapongsa T, et al. Toll-like receptor-2 and -4 in the chorioamniotic membranes in spontaneous labor at term and in preterm parturition that are associated with chorioamnionitis. Am J Obstet Gynecol 2004; 191:1346.</a></li><li><a class="nounderline abstract_t">Abrahams VM, Potter JA, Bhat G, et al. Bacterial modulation of human fetal membrane Toll-like receptor expression. Am J Reprod Immunol 2013; 69:33.</a></li><li><a class="nounderline abstract_t">Wilks M, Wiggins R, Whiley A, et al. Identification and H(2)O(2) production of vaginal lactobacilli from pregnant women at high risk of preterm birth and relation with outcome. J Clin Microbiol 2004; 42:713.</a></li><li><a class="nounderline abstract_t">Waites KB, Katz B, Schelonka RL. Mycoplasmas and ureaplasmas as neonatal pathogens. Clin Microbiol Rev 2005; 18:757.</a></li><li><a class="nounderline abstract_t">Romero R, Miranda J, Kusanovic JP, et al. Clinical chorioamnionitis at term I: microbiology of the amniotic cavity using cultivation and molecular techniques. J Perinat Med 2015; 43:19.</a></li><li><a class="nounderline abstract_t">Yoon BH, Romero R, Park JS, et al. Microbial invasion of the amniotic cavity with Ureaplasma urealyticum is associated with a robust host response in fetal, amniotic, and maternal compartments. Am J Obstet Gynecol 1998; 179:1254.</a></li><li><a class="nounderline abstract_t">Sweeney EL, Dando SJ, Kallapur SG, Knox CL. The Human Ureaplasma Species as Causative Agents of Chorioamnionitis. Clin Microbiol Rev 2017; 30:349.</a></li><li><a class="nounderline abstract_t">Sperling RS, Newton E, Gibbs RS. Intraamniotic infection in low-birth-weight infants. J Infect Dis 1988; 157:113.</a></li><li><a class="nounderline abstract_t">Woodd SL, Montoya A, Barreix M, et al. Incidence of maternal peripartum infection: A systematic review and meta-analysis. PLoS Med 2019; 16:e1002984.</a></li><li><a class="nounderline abstract_t">Kim CJ, Romero R, Chaemsaithong P, et al. Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance. Am J Obstet Gynecol 2015; 213:S29.</a></li><li><a class="nounderline abstract_t">Lieberman E, Lang J, Richardson DK, et al. Intrapartum maternal fever and neonatal outcome. Pediatrics 2000; 105:8.</a></li><li><a class="nounderline abstract_t">Soper DE, Mayhall CG, Dalton HP. Risk factors for intraamniotic infection: a prospective epidemiologic study. Am J Obstet Gynecol 1989; 161:562.</a></li><li><a class="nounderline abstract_t">Frigoletto FD Jr, Lieberman E, Lang JM, et al. A clinical trial of active management of labor. N Engl J Med 1995; 333:745.</a></li><li><a class="nounderline abstract_t">Yoon BH, Romero R, Moon JB, et al. Clinical significance of intra-amniotic inflammation in patients with preterm labor and intact membranes. Am J Obstet Gynecol 2001; 185:1130.</a></li><li><a class="nounderline abstract_t">Seong HS, Lee SE, Kang JH, et al. The frequency of microbial invasion of the amniotic cavity and histologic chorioamnionitis in women at term with intact membranes in the presence or absence of labor. Am J Obstet Gynecol 2008; 199:375.e1.</a></li><li><a class="nounderline abstract_t">Seaward PG, Hannah ME, Myhr TL, et al. International Multicentre Term Prelabor Rupture of Membranes Study: evaluation of predictors of clinical chorioamnionitis and postpartum fever in patients with prelabor rupture of membranes at term. Am J Obstet Gynecol 1997; 177:1024.</a></li><li><a class="nounderline abstract_t">Newton ER, Prihoda TJ, Gibbs RS. Logistic regression analysis of risk factors for intra-amniotic infection. Obstet Gynecol 1989; 73:571.</a></li><li><a class="nounderline abstract_t">Tran SH, Caughey AB, Musci TJ. Meconium-stained amniotic fluid is associated with puerperal infections. Am J Obstet Gynecol 2003; 189:746.</a></li><li><a class="nounderline abstract_t">Cheng YW, Delaney SS, Hopkins LM, Caughey AB. The association between the length of first stage of labor, mode of delivery, and perinatal outcomes in women undergoing induction of labor. Am J Obstet Gynecol 2009; 201:477.e1.</a></li><li><a class="nounderline abstract_t">Park HS, Romero R, Lee SM, et al. Histologic chorioamnionitis is more common after spontaneous labor than after induced labor at term. Placenta 2010; 31:792.</a></li><li><a class="nounderline abstract_t">Soper DE, Mayhall CG, Froggatt JW. Characterization and control of intraamniotic infection in an urban teaching hospital. Am J Obstet Gynecol 1996; 175:304.</a></li><li><a class="nounderline abstract_t">Cohen-Cline HN, Kahn TR, Hutter CM. A population-based study of the risk of repeat clinical chorioamnionitis in Washington State, 1989-2008. Am J Obstet Gynecol 2012; 207:473.e1.</a></li><li><a class="nounderline abstract_t">Ayyar A, Moufarrij S, Turrentine M. Infectious morbidity of speculum versus digital examinations in preterm prelabor rupture of membranes: a systematic review and meta-analysis. J Matern Fetal Neonatal Med 2022; 35:8905.</a></li><li><a class="nounderline abstract_t">Gomez Slagle HB, Hoffman MK, Fonge YN, et al. Incremental risk of clinical chorioamnionitis associated with cervical examination. Am J Obstet Gynecol MFM 2022; 4:100524.</a></li><li><a class="nounderline abstract_t">Cahill AG, Duffy CR, Odibo AO, et al. Number of cervical examinations and risk of intrapartum maternal fever. Obstet Gynecol 2012; 119:1096.</a></li><li><a class="nounderline abstract_t">Mackeen AD, Quinn ST, Movva VC, et al. Intracervical balloon catheter for labor induction after rupture of membranes: a systematic review and meta-analysis. Am J Obstet Gynecol 2021; 224:624.</a></li><li><a class="nounderline abstract_t">Kachikis A, Eckert LO, Walker C, et al. Chorioamnionitis: Case definition &amp; guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine 2019; 37:7610.</a></li><li><a class="nounderline abstract_t">Newton ER. Chorioamnionitis and intraamniotic infection. Clin Obstet Gynecol 1993; 36:795.</a></li><li><a class="nounderline abstract_t">Tita AT, Andrews WW. Diagnosis and management of clinical chorioamnionitis. Clin Perinatol 2010; 37:339.</a></li><li><a class="nounderline abstract_t">Buscicchio G, Giannubilo SR, Bezzeccheri V, et al. Computerized analysis of the fetal heart rate in pregnancies complicated by preterm premature rupture of membranes (pPROM). J Matern Fetal Neonatal Med 2006; 19:39.</a></li><li><a class="nounderline abstract_t">Vandenbroucke L, Doyen M, Le Lous M, et al. Chorioamnionitis following preterm premature rupture of membranes and fetal heart rate variability. PLoS One 2017; 12:e0184924.</a></li><li><a class="nounderline abstract_t">Jain VG, Willis KA, Jobe A, Ambalavanan N. Chorioamnionitis and neonatal outcomes. Pediatr Res 2022; 91:289.</a></li><li><a class="nounderline abstract_t">Rouse DJ, Landon M, Leveno KJ, et al. The Maternal-Fetal Medicine Units cesarean registry: chorioamnionitis at term and its duration-relationship to outcomes. Am J Obstet Gynecol 2004; 191:211.</a></li><li><a class="nounderline abstract_t">Mark SP, Croughan-Minihane MS, Kilpatrick SJ. Chorioamnionitis and uterine function. Obstet Gynecol 2000; 95:909.</a></li><li><a class="nounderline abstract_t">Satin AJ, Maberry MC, Leveno KJ, et al. Chorioamnionitis: a harbinger of dystocia. Obstet Gynecol 1992; 79:913.</a></li><li><a class="nounderline abstract_t">Gibbs RS, Blanco JD, St Clair PJ, Castaneda YS. Quantitative bacteriology of amniotic fluid from women with clinical intraamniotic infection at term. J Infect Dis 1982; 145:1.</a></li><li><a class="nounderline abstract_t">Silver RK, Gibbs RS, Castillo M. Effect of amniotic fluid bacteria on the course of labor in nulliparous women at term. Obstet Gynecol 1986; 68:587.</a></li><li><a class="nounderline abstract_t">Blanco JD, Gibbs RS, Malherbe H, et al. A controlled study of genital mycoplasmas in amniotic fluid from patients with intra-amniotic infection. J Infect Dis 1983; 147:650.</a></li><li><a class="nounderline abstract_t">Gibbs RS, Blanco JD, St Clair PJ, Castaneda YS. Mycoplasma hominis and intrauterine infection in late pregnancy. Sex Transm Dis 1983; 10:303.</a></li><li><a class="nounderline abstract_t">Gibbs RS, Blanco JD, Lipscomb K, St Clair PJ. Asymptomatic parturient women with high-virulence bacteria in the amniotic fluid. Am J Obstet Gynecol 1985; 152:650.</a></li><li><a class="nounderline abstract_t">Newton ER, Schroeder BC, Knape KG, Bennett BL. Epidural analgesia and uterine function. Obstet Gynecol 1995; 85:749.</a></li><li><a class="nounderline abstract_t">Al-Ostad G, Kezouh A, Spence AR, Abenhaim HA. Incidence and risk factors of sepsis mortality in labor, delivery and after birth: population-based study in the USA. J Obstet Gynaecol Res 2015; 41:1201.</a></li><li><a class="nounderline abstract_t">Balki I, Baghirzada L, Walker A, et al. Incidence, morbidity, and associated factors for sepsis in women hospitalized for delivery: a nationwide retrospective observational population-based study in Canada. Can J Anaesth 2022; 69:298.</a></li><li><a class="nounderline abstract_t">Edwards SE, Grobman WA, Lappen JR, et al. Modified obstetric early warning scoring systems (MOEWS): validating the diagnostic performance for severe sepsis in women with chorioamnionitis. Am J Obstet Gynecol 2015; 212:536.e1.</a></li><li><a class="nounderline abstract_t">Hauth JC, Gilstrap LC 3rd, Hankins GD, Connor KD. Term maternal and neonatal complications of acute chorioamnionitis. Obstet Gynecol 1985; 66:59.</a></li><li><a class="nounderline abstract_t">Venkatesh KK, Glover AV, Vladutiu CJ, Stamilio DM. Association of chorioamnionitis and its duration with adverse maternal outcomes by mode of delivery: a cohort study. BJOG 2019; 126:719.</a></li><li><a class="nounderline abstract_t">Holcroft CJ, Askin FB, Patra A, et al. Are histopathologic chorioamnionitis and funisitis associated with metabolic acidosis in the preterm fetus? Am J Obstet Gynecol 2004; 191:2010.</a></li><li><a class="nounderline abstract_t">Queiros da Mota V, Prodhom G, Yan P, et al. Correlation between placental bacterial culture results and histological chorioamnionitis: a prospective study on 376 placentas. J Clin Pathol 2013; 66:243.</a></li><li><a class="nounderline abstract_t">Pettker CM, Buhimschi IA, Magloire LK, et al. Value of placental microbial evaluation in diagnosing intra-amniotic infection. Obstet Gynecol 2007; 109:739.</a></li><li><a class="nounderline abstract_t">Gomez R, Ghezzi F, Romero R, et al. Premature labor and intra-amniotic infection. Clinical aspects and role of the cytokines in diagnosis and pathophysiology. Clin Perinatol 1995; 22:281.</a></li><li><a class="nounderline abstract_t">Gauthier DW, Meyer WJ. Comparison of gram stain, leukocyte esterase activity, and amniotic fluid glucose concentration in predicting amniotic fluid culture results in preterm premature rupture of membranes. Am J Obstet Gynecol 1992; 167:1092.</a></li><li><a class="nounderline abstract_t">Rehbinder EM, Lødrup Carlsen KC, Staff AC, et al. Is amniotic fluid of women with uncomplicated term pregnancies free of bacteria? Am J Obstet Gynecol 2018; 219:289.e1.</a></li><li><a class="nounderline abstract_t">Lisonkova S, Sabr Y, Joseph KS. Diagnosis of subclinical amniotic fluid infection prior to rescue cerclage using gram stain and glucose tests: an individual patient meta-analysis. J Obstet Gynaecol Can 2014; 36:116.</a></li><li><a class="nounderline abstract_t">Abdel-Razeq SS, Buhimschi IA, Bahtiyar MO, et al. Interpretation of amniotic fluid white blood cell count in "bloody tap" amniocenteses in women with symptoms of preterm labor. Obstet Gynecol 2010; 116:344.</a></li><li><a class="nounderline abstract_t">Riggs JW, Blanco JD. Pathophysiology, diagnosis, and management of intraamniotic infection. Semin Perinatol 1998; 22:251.</a></li><li><a class="nounderline abstract_t">Hoskins IA, Marks F, Ordorica SA, Young BK. Leukocyte esterase activity in amniotic fluid: normal values during pregnancy. Am J Perinatol 1990; 7:130.</a></li><li><a class="nounderline abstract_t">Locatelli A, Consonni S, Ghidini A. Preterm labor: approach to decreasing complications of prematurity. Obstet Gynecol Clin North Am 2015; 42:255.</a></li><li><a class="nounderline abstract_t">Yoon BH, Romero R, Park JY, et al. Antibiotic administration can eradicate intra-amniotic infection or intra-amniotic inflammation in a subset of patients with preterm labor and intact membranes. Am J Obstet Gynecol 2019; 221:142.e1.</a></li><li><a class="nounderline abstract_t">Kayem G, Batteux F, Girard N, et al. Predictive value of vaginal IL-6 and TNFα bedside tests repeated until delivery for the prediction of maternal-fetal infection in cases of premature rupture of membranes. Eur J Obstet Gynecol Reprod Biol 2017; 211:8.</a></li><li><a class="nounderline abstract_t">van de Laar R, van der Ham DP, Oei SG, et al. Accuracy of C-reactive protein determination in predicting chorioamnionitis and neonatal infection in pregnant women with premature rupture of membranes: a systematic review. Eur J Obstet Gynecol Reprod Biol 2009; 147:124.</a></li><li><a class="nounderline abstract_t">Trochez-Martinez RD, Smith P, Lamont RF. Use of C-reactive protein as a predictor of chorioamnionitis in preterm prelabour rupture of membranes: a systematic review. BJOG 2007; 114:796.</a></li><li><a class="nounderline abstract_t">Hall M, Hutter J, Suff N, et al. Antenatal diagnosis of chorioamnionitis: A review of the potential role of fetal and placental imaging. Prenat Diagn 2022; 42:1049.</a></li><li><a class="nounderline abstract_t">Ona S, Easter SR, Prabhu M, et al. Diagnostic Validity of the Proposed Eunice Kennedy Shriver National Institute of Child Health and Human Development Criteria for Intrauterine Inflammation or Infection. Obstet Gynecol 2019; 133:33.</a></li><li><a class="nounderline abstract_t">Gilstrap LC 3rd, Cox SM. Acute chorioamnionitis. Obstet Gynecol Clin North Am 1989; 16:373.</a></li><li><a class="nounderline abstract_t">Chapman E, Reveiz L, Illanes E, Bonfill Cosp X. Antibiotic regimens for management of intra-amniotic infection. Cochrane Database Syst Rev 2014; :CD010976.</a></li><li><a class="nounderline abstract_t">Kenyon S, Boulvain M, Neilson JP. Antibiotics for preterm rupture of membranes. Cochrane Database Syst Rev 2013; :CD001058.</a></li><li><a class="nounderline abstract_t">Ohlsson A, Shah VS. Intrapartum antibiotics for known maternal Group B streptococcal colonization. Cochrane Database Syst Rev 2014; :CD007467.</a></li><li><a class="nounderline abstract_t">Lyell DJ, Pullen K, Fuh K, et al. Daily compared with 8-hour gentamicin for the treatment of intrapartum chorioamnionitis: a randomized controlled trial. Obstet Gynecol 2010; 115:344.</a></li><li><a class="nounderline abstract_t">Mackeen AD, Packard RE, Ota E, Speer L. Antibiotic regimens for postpartum endometritis. Cochrane Database Syst Rev 2015; :CD001067.</a></li><li><a class="nounderline abstract_t">Locksmith GJ, Chin A, Vu T, et al. High compared with standard gentamicin dosing for chorioamnionitis: a comparison of maternal and fetal serum drug levels. Obstet Gynecol 2005; 105:473.</a></li><li><a class="nounderline abstract_t">Alrowaily N, D'Souza R, Dong S, et al. Determining the optimal antibiotic regimen for chorioamnionitis: A systematic review and meta-analysis. Acta Obstet Gynecol Scand 2021; 100:818.</a></li><li><a class="nounderline abstract_t">Maberry MC, Gilstrap LC 3rd, Bawdon R, et al. Anaerobic coverage for intra-amnionic infection: maternal and perinatal impact. Am J Perinatol 1991; 8:338.</a></li><li><a class="nounderline abstract_t">Conde-Agudelo A, Romero R, Jung EJ, Garcia Sánchez ÁJ. Management of clinical chorioamnionitis: an evidence-based approach. Am J Obstet Gynecol 2020; 223:848.</a></li><li><a class="nounderline abstract_t">Tita AT, Szychowski JM, Boggess K, et al. Adjunctive Azithromycin Prophylaxis for Cesarean Delivery. N Engl J Med 2016; 375:1231.</a></li><li><a class="nounderline abstract_t">Tita AT, Rouse DJ, Blackwell S, et al. Emerging concepts in antibiotic prophylaxis for cesarean delivery: a systematic review. Obstet Gynecol 2009; 113:675.</a></li><li><a class="nounderline abstract_t">Impey LW, Greenwood CE, Black RS, et al. The relationship between intrapartum maternal fever and neonatal acidosis as risk factors for neonatal encephalopathy. Am J Obstet Gynecol 2008; 198:49.e1.</a></li><li><a class="nounderline abstract_t">Dinsmoor MJ, Newton ER, Gibbs RS. A randomized, double-blind, placebo-controlled trial of oral antibiotic therapy following intravenous antibiotic therapy for postpartum endometritis. Obstet Gynecol 1991; 77:60.</a></li><li><a class="nounderline abstract_t">Black LP, Hinson L, Duff P. Limited course of antibiotic treatment for chorioamnionitis. Obstet Gynecol 2012; 119:1102.</a></li><li><a class="nounderline abstract_t">Venkatesh KK, Jackson W, Hughes BL, et al. Association of chorioamnionitis and its duration with neonatal morbidity and mortality. J Perinatol 2019; 39:673.</a></li><li><a class="nounderline abstract_t">Yoder PR, Gibbs RS, Blanco JD, et al. A prospective, controlled study of maternal and perinatal outcome after intra-amniotic infection at term. Am J Obstet Gynecol 1983; 145:695.</a></li><li><a class="nounderline abstract_t">Aziz N, Cheng YW, Caughey AB. Neonatal outcomes in the setting of preterm premature rupture of membranes complicated by chorioamnionitis. J Matern Fetal Neonatal Med 2009; 22:780.</a></li><li><a class="nounderline abstract_t">Beck C, Gallagher K, Taylor LA, et al. Chorioamnionitis and Risk for Maternal and Neonatal Sepsis: A Systematic Review and Meta-analysis. Obstet Gynecol 2021; 137:1007.</a></li><li><a class="nounderline abstract_t">Morales WJ, Washington SR 3rd, Lazar AJ. The effect of chorioamnionitis on perinatal outcome in preterm gestation. J Perinatol 1987; 7:105.</a></li><li><a class="nounderline abstract_t">Shatrov JG, Birch SC, Lam LT, et al. Chorioamnionitis and cerebral palsy: a meta-analysis. Obstet Gynecol 2010; 116:387.</a></li><li><a class="nounderline abstract_t">Sung JH, Choi SJ, Oh SY, Roh CR. Should the diagnostic criteria for suspected clinical chorioamnionitis be changed? J Matern Fetal Neonatal Med 2021; 34:824.</a></li><li><a class="nounderline abstract_t">Vander Haar E, Gyamfi-Bannerman C. Chorioamnionitis and Neurocognitive Development at Age 2 Years. Obstet Gynecol 2016; 127:437.</a></li><li><a class="nounderline abstract_t">Pappas A, Kendrick DE, Shankaran S, et al. Chorioamnionitis and early childhood outcomes among extremely low-gestational-age neonates. JAMA Pediatr 2014; 168:137.</a></li><li><a class="nounderline abstract_t">Gomez R, Romero R, Ghezzi F, et al. The fetal inflammatory response syndrome. Am J Obstet Gynecol 1998; 179:194.</a></li><li><a class="nounderline abstract_t">Perlman JM. White matter injury in the preterm infant: an important determination of abnormal neurodevelopment outcome. Early Hum Dev 1998; 53:99.</a></li><li><a class="nounderline abstract_t">Leviton A, Paneth N, Reuss ML, et al. Maternal infection, fetal inflammatory response, and brain damage in very low birth weight infants. Developmental Epidemiology Network Investigators. Pediatr Res 1999; 46:566.</a></li><li><a class="nounderline abstract_t">Nelson KB, Ellenberg JH. Antecedents of cerebral palsy. I. Univariate analysis of risks. Am J Dis Child 1985; 139:1031.</a></li><li><a class="nounderline abstract_t">Wu YW, Colford JM Jr. Chorioamnionitis as a risk factor for cerebral palsy: A meta-analysis. JAMA 2000; 284:1417.</a></li><li><a class="nounderline abstract_t">Yoon BH, Jun JK, Romero R, et al. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol 1997; 177:19.</a></li><li><a class="nounderline abstract_t">Williams MC, O'Brien WF, Nelson RN, Spellacy WN. Histologic chorioamnionitis is associated with fetal growth restriction in term and preterm infants. Am J Obstet Gynecol 2000; 183:1094.</a></li><li><a class="nounderline abstract_t">Kadhim H, Tabarki B, Verellen G, et al. Inflammatory cytokines in the pathogenesis of periventricular leukomalacia. Neurology 2001; 56:1278.</a></li><li><a class="nounderline abstract_t">Rodts-Palenik S, Wyatt-Ashmead J, Pang Y, et al. Maternal infection-induced white matter injury is reduced by treatment with interleukin-10. Am J Obstet Gynecol 2004; 191:1387.</a></li><li><a class="nounderline abstract_t">Pacora P, Chaiworapongsa T, Maymon E, et al. Funisitis and chorionic vasculitis: the histological counterpart of the fetal inflammatory response syndrome. J Matern Fetal Neonatal Med 2002; 11:18.</a></li><li><a class="nounderline abstract_t">Hofer N, Kothari R, Morris N, et al. The fetal inflammatory response syndrome is a risk factor for morbidity in preterm neonates. Am J Obstet Gynecol 2013; 209:542.e1.</a></li><li><a class="nounderline abstract_t">Yoon BH, Romero R, Park JS, et al. The relationship among inflammatory lesions of the umbilical cord (funisitis), umbilical cord plasma interleukin 6 concentration, amniotic fluid infection, and neonatal sepsis. Am J Obstet Gynecol 2000; 183:1124.</a></li><li><a class="nounderline abstract_t">Jobe AH. Antenatal associations with lung maturation and infection. J Perinatol 2005; 25 Suppl 2:S31.</a></li><li><a class="nounderline abstract_t">Mittendorf R, Montag AG, MacMillan W, et al. Components of the systemic fetal inflammatory response syndrome as predictors of impaired neurologic outcomes in children. Am J Obstet Gynecol 2003; 188:1438.</a></li><li><a class="nounderline abstract_t">Romero R, Gomez R, Ghezzi F, et al. A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition. Am J Obstet Gynecol 1998; 179:186.</a></li><li><a class="nounderline abstract_t">Hagberg H, Mallard C, Ferriero DM, et al. The role of inflammation in perinatal brain injury. Nat Rev Neurol 2015; 11:192.</a></li><li><a class="nounderline abstract_t">Debillon T, Gras-Leguen C, Vérielle V, et al. Intrauterine infection induces programmed cell death in rabbit periventricular white matter. Pediatr Res 2000; 47:736.</a></li><li><a class="nounderline abstract_t">Dammann O, Leviton A. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res 1997; 42:1.</a></li><li><a class="nounderline abstract_t">Lu HY, Zhang Q, Wang QX, Lu JY. Contribution of Histologic Chorioamnionitis and Fetal Inflammatory Response Syndrome to Increased Risk of Brain Injury in Infants With Preterm Premature Rupture of Membranes. Pediatr Neurol 2016; 61:94.</a></li><li><a class="nounderline abstract_t">Yesilirmak DC, Kumral A, Baskin H, et al. Activated protein C reduces endotoxin-induced white matter injury in the developing rat brain. Brain Res 2007; 1164:14.</a></li></ol></div><div id="topicVersionRevision">Topic 6762 Version 84.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26855098" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Evaluation and Management of Women and Newborns With a Maternal Diagnosis of Chorioamnionitis: Summary of a Workshop.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26855113" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Lost in Translation: The Changing Language of Our Specialty.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28742677" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Committee Opinion No. 712: Intrapartum Management of Intraamniotic Infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33544519" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Clinical chorioamnionitis at term X: microbiology, clinical signs, placental pathology, and neonatal bacteremia - implications for clinical care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19046766" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : The involvement of human amnion in histologic chorioamnionitis is an indicator that a fetal and an intra-amniotic inflammatory response is more likely and severe: clinical implications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32373122" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Immunobiology of Acute Chorioamnionitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11165729" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Antibacterial properties of human amnion and chorion in vitro.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17346544" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Natural antimicrobial production by the amnion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15507964" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Toll-like receptor-2 and -4 in the chorioamniotic membranes in spontaneous labor at term and in preterm parturition that are associated with chorioamnionitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22967004" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Bacterial modulation of human fetal membrane Toll-like receptor expression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14766841" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Identification and H(2)O(2) production of vaginal lactobacilli from pregnant women at high risk of preterm birth and relation with outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16223956" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Mycoplasmas and ureaplasmas as neonatal pathogens.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25720095" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Clinical chorioamnionitis at term I: microbiology of the amniotic cavity using cultivation and molecular techniques.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9822511" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Microbial invasion of the amniotic cavity with Ureaplasma urealyticum is associated with a robust host response in fetal, amniotic, and maternal compartments.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27974410" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : The Human Ureaplasma Species as Causative Agents of Chorioamnionitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3335795" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Intraamniotic infection in low-birth-weight infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31821329" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Incidence of maternal peripartum infection: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26428501" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10617697" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Intrapartum maternal fever and neonatal outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2782335" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Risk factors for intraamniotic infection: a prospective epidemiologic study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7643880" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : A clinical trial of active management of labor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11717646" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Clinical significance of intra-amniotic inflammation in patients with preterm labor and intact membranes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18928978" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : The frequency of microbial invasion of the amniotic cavity and histologic chorioamnionitis in women at term with intact membranes in the presence or absence of labor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9396886" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : International Multicentre Term Prelabor Rupture of Membranes Study: evaluation of predictors of clinical chorioamnionitis and postpartum fever in patients with prelabor rupture of membranes at term.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2927851" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Logistic regression analysis of risk factors for intra-amniotic infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14526306" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Meconium-stained amniotic fluid is associated with puerperal infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19608153" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : The association between the length of first stage of labor, mode of delivery, and perinatal outcomes in women undergoing induction of labor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20655108" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Histologic chorioamnionitis is more common after spontaneous labor than after induced labor at term.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8765246" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Characterization and control of intraamniotic infection in an urban teaching hospital.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22964068" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : A population-based study of the risk of repeat clinical chorioamnionitis in Washington State, 1989-2008.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34818968" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Infectious morbidity of speculum versus digital examinations in preterm prelabor rupture of membranes: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34768023" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Incremental risk of clinical chorioamnionitis associated with cervical examination.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22617572" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Number of cervical examinations and risk of intrapartum maternal fever.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33689751" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Intracervical balloon catheter for labor induction after rupture of membranes: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31783982" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Chorioamnionitis: Case definition&amp;guidelines for data collection, analysis, and presentation of immunization safety data.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8293582" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Chorioamnionitis and intraamniotic infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20569811" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Diagnosis and management of clinical chorioamnionitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16492590" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Computerized analysis of the fetal heart rate in pregnancies complicated by preterm premature rupture of membranes (pPROM).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28945767" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Chorioamnionitis following preterm premature rupture of membranes and fetal heart rate variability.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34211129" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Chorioamnionitis and neonatal outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15295368" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : The Maternal-Fetal Medicine Units cesarean registry: chorioamnionitis at term and its duration-relationship to outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10831982" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Chorioamnionitis and uterine function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1579312" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Chorioamnionitis: a harbinger of dystocia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7033397" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Quantitative bacteriology of amniotic fluid from women with clinical intraamniotic infection at term.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3763067" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Effect of amniotic fluid bacteria on the course of labor in nulliparous women at term.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6842005" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : A controlled study of genital mycoplasmas in amniotic fluid from patients with intra-amniotic infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6665672" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Mycoplasma hominis and intrauterine infection in late pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4025423" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Asymptomatic parturient women with high-virulence bacteria in the amniotic fluid.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7724107" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Epidural analgesia and uterine function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25976287" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Incidence and risk factors of sepsis mortality in labor, delivery and after birth: population-based study in the USA.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34939139" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Incidence, morbidity, and associated factors for sepsis in women hospitalized for delivery: a nationwide retrospective observational population-based study in Canada.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25446705" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Modified obstetric early warning scoring systems (MOEWS): validating the diagnostic performance for severe sepsis in women with chorioamnionitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4011072" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Term maternal and neonatal complications of acute chorioamnionitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30485648" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Association of chorioamnionitis and its duration with adverse maternal outcomes by mode of delivery: a cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15592284" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Are histopathologic chorioamnionitis and funisitis associated with metabolic acidosis in the preterm fetus?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23268318" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Correlation between placental bacterial culture results and histological chorioamnionitis: a prospective study on 376 placentas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17329528" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Value of placental microbial evaluation in diagnosing intra-amniotic infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7671540" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Premature labor and intra-amniotic infection. Clinical aspects and role of the cytokines in diagnosis and pathophysiology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1384334" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Comparison of gram stain, leukocyte esterase activity, and amniotic fluid glucose concentration in predicting amniotic fluid culture results in preterm premature rupture of membranes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29852156" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Is amniotic fluid of women with uncomplicated term pregnancies free of bacteria?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24518909" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Diagnosis of subclinical amniotic fluid infection prior to rescue cerclage using gram stain and glucose tests: an individual patient meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20664395" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Interpretation of amniotic fluid white blood cell count in "bloody tap" amniocenteses in women with symptoms of preterm labor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9738989" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Pathophysiology, diagnosis, and management of intraamniotic infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2331274" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Leukocyte esterase activity in amniotic fluid: normal values during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26002165" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Preterm labor: approach to decreasing complications of prematurity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30928566" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Antibiotic administration can eradicate intra-amniotic infection or intra-amniotic inflammation in a subset of patients with preterm labor and intact membranes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28160689" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Predictive value of vaginal IL-6 and TNFαbedside tests repeated until delivery for the prediction of maternal-fetal infection in cases of premature rupture of membranes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19819609" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Accuracy of C-reactive protein determination in predicting chorioamnionitis and neonatal infection in pregnant women with premature rupture of membranes: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17567416" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Use of C-reactive protein as a predictor of chorioamnionitis in preterm prelabour rupture of membranes: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35670265" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Antenatal diagnosis of chorioamnionitis: A review of the potential role of fetal and placental imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30531562" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Diagnostic Validity of the Proposed Eunice Kennedy Shriver National Institute of Child Health and Human Development Criteria for Intrauterine Inflammation or Infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2674804" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Acute chorioamnionitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25526426" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Antibiotic regimens for management of intra-amniotic infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24297389" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Antibiotics for preterm rupture of membranes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24915629" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Intrapartum antibiotics for known maternal Group B streptococcal colonization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20093909" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Daily compared with 8-hour gentamicin for the treatment of intrapartum chorioamnionitis: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25922861" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Antibiotic regimens for postpartum endometritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15738010" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : High compared with standard gentamicin dosing for chorioamnionitis: a comparison of maternal and fetal serum drug levels.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33191493" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Determining the optimal antibiotic regimen for chorioamnionitis: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1760067" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Anaerobic coverage for intra-amnionic infection: maternal and perinatal impact.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33007269" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Management of clinical chorioamnionitis: an evidence-based approach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27682034" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Adjunctive Azithromycin Prophylaxis for Cesarean Delivery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19300334" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Emerging concepts in antibiotic prophylaxis for cesarean delivery: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18166304" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : The relationship between intrapartum maternal fever and neonatal acidosis as risk factors for neonatal encephalopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1984229" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : A randomized, double-blind, placebo-controlled trial of oral antibiotic therapy following intravenous antibiotic therapy for postpartum endometritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22617573" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Limited course of antibiotic treatment for chorioamnionitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30723279" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Association of chorioamnionitis and its duration with neonatal morbidity and mortality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6829656" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : A prospective, controlled study of maternal and perinatal outcome after intra-amniotic infection at term.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19557664" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Neonatal outcomes in the setting of preterm premature rupture of membranes complicated by chorioamnionitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33957655" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Chorioamnionitis and Risk for Maternal and Neonatal Sepsis: A Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3505603" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : The effect of chorioamnionitis on perinatal outcome in preterm gestation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20664400" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Chorioamnionitis and cerebral palsy: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31084245" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Should the diagnostic criteria for suspected clinical chorioamnionitis be changed?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26855093" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Chorioamnionitis and Neurocognitive Development at Age 2 Years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24378638" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Chorioamnionitis and early childhood outcomes among extremely low-gestational-age neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9704787" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : The fetal inflammatory response syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10195704" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : White matter injury in the preterm infant: an important determination of abnormal neurodevelopment outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10541320" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Maternal infection, fetal inflammatory response, and brain damage in very low birth weight infants. Developmental Epidemiology Network Investigators.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4036890" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Antecedents of cerebral palsy. I. Univariate analysis of risks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10989405" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Chorioamnionitis as a risk factor for cerebral palsy: A meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9240577" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11084547" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Histologic chorioamnionitis is associated with fetal growth restriction in term and preterm infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11376173" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Inflammatory cytokines in the pathogenesis of periventricular leukomalacia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15507970" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Maternal infection-induced white matter injury is reduced by treatment with interleukin-10.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12380603" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Funisitis and chorionic vasculitis: the histological counterpart of the fetal inflammatory response syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23994220" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : The fetal inflammatory response syndrome is a risk factor for morbidity in preterm neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11084553" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : The relationship among inflammatory lesions of the umbilical cord (funisitis), umbilical cord plasma interleukin 6 concentration, amniotic fluid infection, and neonatal sepsis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15861169" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Antenatal associations with lung maturation and infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12824976" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Components of the systemic fetal inflammatory response syndrome as predictors of impaired neurologic outcomes in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9704786" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25686754" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : The role of inflammation in perinatal brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10832730" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Intrauterine infection induces programmed cell death in rabbit periventricular white matter.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9212029" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27353694" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Contribution of Histologic Chorioamnionitis and Fetal Inflammatory Response Syndrome to Increased Risk of Brain Injury in Infants With Preterm Premature Rupture of Membranes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17644074" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Activated protein C reduces endotoxin-induced white matter injury in the developing rat brain.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
